vs
Side-by-side financial comparison of JFrog Ltd (FROG) and PTC THERAPEUTICS, INC. (PTCT). Click either name above to swap in a different company.
PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $145.3M, roughly 1.1× JFrog Ltd). JFrog Ltd runs the higher net margin — -10.5% vs -82.0%, a 71.5% gap on every dollar of revenue. On growth, JFrog Ltd posted the faster year-over-year revenue change (25.2% vs -22.7%). JFrog Ltd produced more free cash flow last quarter ($49.9M vs $-36.6M). Over the past eight quarters, JFrog Ltd's revenue compounded faster (20.4% CAGR vs -11.5%).
JFrog Ltd is a global DevOps technology provider that delivers end-to-end software release, artifact management, and security solutions. It serves clients across tech, finance, retail, and manufacturing sectors, helping teams streamline development and delivery workflows for cloud, on-premises, and hybrid infrastructure.
PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.
FROG vs PTCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $145.3M | $164.7M |
| Net Profit | $-15.2M | $-135.0M |
| Gross Margin | 77.9% | — |
| Operating Margin | -14.7% | -43.3% |
| Net Margin | -10.5% | -82.0% |
| Revenue YoY | 25.2% | -22.7% |
| Net Profit YoY | 34.4% | -104.8% |
| EPS (diluted) | $-0.13 | $-1.63 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $145.3M | $164.7M | ||
| Q3 25 | $136.9M | $211.0M | ||
| Q2 25 | $127.2M | $178.9M | ||
| Q1 25 | $122.4M | $1.2B | ||
| Q4 24 | $116.1M | $213.2M | ||
| Q3 24 | $109.1M | $196.8M | ||
| Q2 24 | $103.0M | $186.7M | ||
| Q1 24 | $100.3M | $210.1M |
| Q4 25 | $-15.2M | $-135.0M | ||
| Q3 25 | $-16.4M | $15.9M | ||
| Q2 25 | $-21.7M | $-64.8M | ||
| Q1 25 | $-18.5M | $866.6M | ||
| Q4 24 | $-23.2M | $-65.9M | ||
| Q3 24 | $-22.9M | $-106.7M | ||
| Q2 24 | $-14.3M | $-99.2M | ||
| Q1 24 | $-8.8M | $-91.6M |
| Q4 25 | 77.9% | — | ||
| Q3 25 | 77.4% | — | ||
| Q2 25 | 76.3% | — | ||
| Q1 25 | 75.3% | — | ||
| Q4 24 | 75.4% | — | ||
| Q3 24 | 75.0% | — | ||
| Q2 24 | 78.8% | — | ||
| Q1 24 | 79.5% | — |
| Q4 25 | -14.7% | -43.3% | ||
| Q3 25 | -15.8% | 1.4% | ||
| Q2 25 | -20.4% | -19.5% | ||
| Q1 25 | -18.8% | 82.5% | ||
| Q4 24 | -21.9% | -76.2% | ||
| Q3 24 | -27.4% | -27.7% | ||
| Q2 24 | -18.6% | -21.5% | ||
| Q1 24 | -16.6% | -21.6% |
| Q4 25 | -10.5% | -82.0% | ||
| Q3 25 | -12.0% | 7.5% | ||
| Q2 25 | -17.0% | -36.3% | ||
| Q1 25 | -15.1% | 73.7% | ||
| Q4 24 | -20.0% | -30.9% | ||
| Q3 24 | -21.0% | -54.2% | ||
| Q2 24 | -13.9% | -53.1% | ||
| Q1 24 | -8.8% | -43.6% |
| Q4 25 | $-0.13 | $-1.63 | ||
| Q3 25 | $-0.14 | $0.20 | ||
| Q2 25 | $-0.19 | $-0.83 | ||
| Q1 25 | $-0.16 | $10.04 | ||
| Q4 24 | $-0.21 | $-0.85 | ||
| Q3 24 | $-0.21 | $-1.39 | ||
| Q2 24 | $-0.13 | $-1.29 | ||
| Q1 24 | $-0.08 | $-1.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $704.4M | $1.9B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $887.4M | $-205.3M |
| Total Assets | $1.3B | $2.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $704.4M | $1.9B | ||
| Q3 25 | $651.1M | $1.7B | ||
| Q2 25 | $611.7M | $2.0B | ||
| Q1 25 | $563.5M | $2.0B | ||
| Q4 24 | $522.0M | $1.1B | ||
| Q3 24 | $467.8M | $1.0B | ||
| Q2 24 | $591.3M | $1.1B | ||
| Q1 24 | $579.6M | $884.8M |
| Q4 25 | $887.4M | $-205.3M | ||
| Q3 25 | $859.4M | $-155.8M | ||
| Q2 25 | $826.5M | $-206.5M | ||
| Q1 25 | $800.0M | $-185.8M | ||
| Q4 24 | $773.5M | $-1.1B | ||
| Q3 24 | $756.2M | $-1.1B | ||
| Q2 24 | $721.4M | $-980.2M | ||
| Q1 24 | $707.8M | $-893.9M |
| Q4 25 | $1.3B | $2.9B | ||
| Q3 25 | $1.3B | $2.6B | ||
| Q2 25 | $1.2B | $2.6B | ||
| Q1 25 | $1.2B | $2.7B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.1B | $1.8B | ||
| Q2 24 | $1.0B | $1.9B | ||
| Q1 24 | $997.1M | $1.8B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $50.7M | $-34.3M |
| Free Cash FlowOCF − Capex | $49.9M | $-36.6M |
| FCF MarginFCF / Revenue | 34.3% | -22.3% |
| Capex IntensityCapex / Revenue | 0.6% | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $142.3M | $702.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $50.7M | $-34.3M | ||
| Q3 25 | $30.2M | $-66.3M | ||
| Q2 25 | $36.1M | $-58.3M | ||
| Q1 25 | $28.8M | $870.1M | ||
| Q4 24 | $49.1M | $-30.0M | ||
| Q3 24 | $27.6M | $-77.0M | ||
| Q2 24 | $16.7M | $-71.5M | ||
| Q1 24 | $17.5M | $70.8M |
| Q4 25 | $49.9M | $-36.6M | ||
| Q3 25 | $28.8M | $-69.7M | ||
| Q2 25 | $35.5M | $-59.6M | ||
| Q1 25 | $28.1M | $868.4M | ||
| Q4 24 | $48.5M | $-33.8M | ||
| Q3 24 | $26.7M | $-77.5M | ||
| Q2 24 | $16.0M | $-78.8M | ||
| Q1 24 | $16.6M | $61.2M |
| Q4 25 | 34.3% | -22.3% | ||
| Q3 25 | 21.0% | -33.1% | ||
| Q2 25 | 27.9% | -33.3% | ||
| Q1 25 | 23.0% | 73.8% | ||
| Q4 24 | 41.8% | -15.8% | ||
| Q3 24 | 24.5% | -39.4% | ||
| Q2 24 | 15.5% | -42.2% | ||
| Q1 24 | 16.6% | 29.1% |
| Q4 25 | 0.6% | 1.4% | ||
| Q3 25 | 1.0% | 1.6% | ||
| Q2 25 | 0.5% | 0.7% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 0.5% | 1.8% | ||
| Q3 24 | 0.9% | 0.3% | ||
| Q2 24 | 0.7% | 4.0% | ||
| Q1 24 | 0.8% | 4.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | -4.17× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
